PMID- 35103559
OWN - NLM
STAT- MEDLINE
DCOM- 20220223
LR  - 20220501
IS  - 1651-226X (Electronic)
IS  - 0284-186X (Linking)
VI  - 61
IP  - 3
DP  - 2022 Mar
TI  - Long-term satisfaction with curative treatment and follow-up in prostate cancer 
      survivors.
PG  - 357-362
LID - 10.1080/0284186X.2021.2006775 [doi]
AB  - PURPOSE: In a cross-sectional observational study to explore long-term 
      satisfaction with treatment among men who had undergone radical prostatectomy 
      (RP) or definitive pelvic radiotherapy (RT) for prostate cancer (PCa). METHODS: 
      After mean 7 years from therapy (range: 6-8), 431 PCa-survivors (RP: n = 313, RT: 
      n = 118) completed a mailed questionnaire assessing persistent treatment-related 
      adverse effects (AEs) (Expanded Prostate cancer Index Composite [EPIC-26]) and 
      seven Quality indicators describing satisfaction with the health care service 
      following a most often general practitioner (GP)-led follow-up plan. A logistic 
      regression model evaluated the associations between long-term satisfaction and 
      treatment modality, age, the seven satisfaction-related Quality indicators, and 
      persistent AEs. The significance level was set at p< .05. RESULTS: Four of five 
      (81%) PCa-survivors reported long-term satisfaction with their treatment. In a 
      multivariable model, satisfaction was positively associated with sufficient 
      information about treatment and AEs, patient-perceived sufficient cooperation 
      between the hospital and the GP and sufficient follow-up of AEs (ref.: 
      insufficient). Age >/=70 years (ref.: <70) and a rising summary score within the 
      EPIC-26 sexual domain additionally increased long-term satisfaction. The 
      treatment modality itself (RP versus RT) did not significantly impact on 
      satisfaction. CONCLUSIONS: The majority of curatively treated PCa-survivors are 
      satisfied with their treatment more than 5 years after primary therapy. 
      Sufficient information, improved cooperation between the hospital specialists and 
      the responsible GP and optimized follow-up of AEs may further increase long-term 
      satisfaction among prostatectomized and irradiated PCa-survivors.
FAU - Monsen, Kari V
AU  - Monsen KV
AD  - Section for Clinical Cancer Research, Oslo University Hospital, Oslo, Norway.
AD  - Faculty of Medicine, University of Oslo, Norway.
FAU - Fossa, Sophie D
AU  - Fossa SD
AD  - Section for Clinical Cancer Research, Oslo University Hospital, Oslo, Norway.
AD  - Faculty of Medicine, University of Oslo, Norway.
FAU - Myklebust, Tor A
AU  - Myklebust TA
AUID- ORCID: 0000-0003-4645-1635
AD  - Department of Research and Innovation, More and Romsdal Hospital Trust, Alesund, 
      Norway.
AD  - Cancer Registry of Norway, Oslo, Norway.
FAU - Smeland, Sigbjorn
AU  - Smeland S
AD  - Faculty of Medicine, University of Oslo, Norway.
AD  - Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway.
FAU - Dahl, Alv A
AU  - Dahl AA
AD  - Section for Clinical Cancer Research, Oslo University Hospital, Oslo, Norway.
AD  - Faculty of Medicine, University of Oslo, Norway.
FAU - Stensvold, Andreas
AU  - Stensvold A
AD  - Division of Clinical Oncology, Ostfold Hospital Trust, Kalnes, Norway.
LA  - eng
PT  - Journal Article
PT  - Observational Study
DEP - 20220201
PL  - Sweden
TA  - Acta Oncol
JT  - Acta oncologica (Stockholm, Sweden)
JID - 8709065
SB  - IM
MH  - Aged
MH  - *Cancer Survivors
MH  - Cross-Sectional Studies
MH  - Follow-Up Studies
MH  - Humans
MH  - Male
MH  - Personal Satisfaction
MH  - Prostate
MH  - Prostatectomy/adverse effects
MH  - *Prostatic Neoplasms/etiology/radiotherapy
MH  - Quality of Life
MH  - Survivors
OTO - NOTNLM
OT  - Prostate cancer
OT  - general practitioner
OT  - prostatectomy
OT  - radiotherapy
OT  - satisfaction
EDAT- 2022/02/02 06:00
MHDA- 2022/02/24 06:00
CRDT- 2022/02/01 12:13
PHST- 2022/02/02 06:00 [pubmed]
PHST- 2022/02/24 06:00 [medline]
PHST- 2022/02/01 12:13 [entrez]
AID - 10.1080/0284186X.2021.2006775 [doi]
PST - ppublish
SO  - Acta Oncol. 2022 Mar;61(3):357-362. doi: 10.1080/0284186X.2021.2006775. Epub 2022 
      Feb 1.